Moreover, OVCAR-5 CXCR4+CD133+ cells migrated toward the CXCR4 ligand CXCL12, were less sensitive to the most popular chemotherapeutic agent utilized in ovarian cancer, cisplatin, and over expressed the drug resistance transporter ABCG2. Here, CXCL12 is linked to ovarian carcinoma.